1. Pink Sheet
  2. >>Market Access
  3. >>Pricing Debate

‘Value-Based’ Price Negotiation: Define Your Terms

 
• By Michael McCaughan

The US Centers for Medicare & Medicaid Services sees the new price negotiation authority as an opportunity to build ‘a common definition of value.’ That is a worthy goal – and a tall order.

Value Highlighted
• Source: Shutterstock

US Centers for Medicare & Medicaid Services Chief Operating Officer Jonathan Blum has spent his career engaged in all aspects of federal payment for pharmaceuticals.

He has tackled the issue on Capitol Hill as a key aid to former Sen. Max Baucus (D-Mont.) during the Medicare Part D/Medicare Modernization Act legislative debate in the early...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Pricing Debate

More from Market Access

Spain Slashes Wait Between EU Drug Authorization And Financing Decisions

 
• By Francesca Bruce

Spanish authorities say that that timelines for drug reimbursement decisions can be improved further with the right submissions from companies.

Spain Beats England To Tevimbra Reimbursement Recommendations

 
• By Francesca Bruce

Spanish authorities have published more pricing and reimbursement reports as part of a new drive to increase transparency.

‘Tectonic’ Arkansas PBM Legislation May Upend Industry

 
• By Tim Casey

Industry will fight hard to prevent other states or the federal government from adopting measures similar to Arkansas' law preventing PBMs from owning pharmacies.